In evaluating the tumor size in the group with an elevated CRP, the majority had a tumor size > 8 cm (pT2, according to the 5th Edition 2020 WHO [14]) while the group with low CRP levels was mostly represented by chondrosarcomas with <8 cm size (pT1) (Table 2 and Figure 2). The gene discussed is CRP; the disease is chondrosarcoma.